About: Successful treatment with nab-paclitaxel after hypersensitivity reaction to paclitaxel and docetaxel

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Successful treatment with nab-paclitaxel after hypersensitivity reaction to paclitaxel and docetaxel Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 14 May 2013

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) bài báo khoa học (vi) article scientifique (fr) artículu científicu espublizáu en 2013 (ast) наукова стаття, опублікована в травні 2013 (uk) مقالة علمية نشرت في 14 مايو 2013 (ar) scientific article published on 14 May 2013 (en)
publication date	wds:Q37390136-4912489F-056F-4E51-89A1-C958B03FEADE
publication date	2013-05-14 00:00:00Z (xsd:dateTime)
cites work	wds:Q37390136-7050E219-A3EC-472D-82C1-1659D01C00C1 wds:Q37390136-966A829A-C665-47FB-B3F3-4C95E5C95E9A wds:Q37390136-BBF6AC4E-E42D-421E-AF90-137222242B88 wds:Q37390136-D21FB50E-0BCE-4E07-A8E0-2654AF5721E7 wds:Q37390136-F43A9C80-E172-4987-BE64-37B5A47462B1
cites work	A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: a Gynecologic Oncology Group study Successful parenteral desensitization to paclitaxel Abraxane for the treatment of gynecologic cancer patients with severe hypersensitivity reactions to paclitaxel Cross-sensitivity between paclitaxel and docetaxel in a women's cancers program Paclitaxel-associated hypersensitivity reaction despite high-dose steroids and prolonged infusions
author name string	wds:Q37390136-60C9EE9B-5B48-4CC0-BA72-5E5A3F9CE893 wds:Q37390136-7AD655E3-6663-40E1-98DC-BE1D271EC2D9 wds:Q37390136-A2CABAC8-3E48-4D66-A5E3-5F8FD4AE31E7 wds:Q37390136-A52733CB-5D54-4BCE-8B6D-69AE7488F28B wds:Q37390136-D2D7F0E5-3E52-43D4-810E-F5F0E666A2F9
author name string	Giuseppe Del Priore Maria C B de Leon Lauren Hutchinson Barbra Greene Sridhar Bolla
rdfs:label	Successful treatment with nab-paclitaxel after hypersensitivity reaction to paclitaxel and docetaxel (en) Successful treatment with nab-paclitaxel after hypersensitivity reaction to paclitaxel and docetaxel (nl) Successful treatment with nab-paclitaxel after hypersensitivity reaction to paclitaxel and docetaxel (ast)
skos:prefLabel	Successful treatment with nab-paclitaxel after hypersensitivity reaction to paclitaxel and docetaxel (en) Successful treatment with nab-paclitaxel after hypersensitivity reaction to paclitaxel and docetaxel (nl) Successful treatment with nab-paclitaxel after hypersensitivity reaction to paclitaxel and docetaxel (ast)
name	Successful treatment with nab-paclitaxel after hypersensitivity reaction to paclitaxel and docetaxel (en) Successful treatment with nab-paclitaxel after hypersensitivity reaction to paclitaxel and docetaxel (nl) Successful treatment with nab-paclitaxel after hypersensitivity reaction to paclitaxel and docetaxel (ast)
title	wds:Q37390136-1D0389F8-7CFC-43D1-B9F6-4E5DD3CA94B1
title	Successful treatment with nab-paclitaxel after hypersensitivity reaction to paclitaxel and docetaxel (en)
page(s)	wds:Q37390136-BAD9153E-1519-41DE-AA3F-B78A0D622C36
page(s)	70-71
instance of	wds:Q37390136-918DF540-1F1F-4F6B-9F65-C5B1CD551EB4
instance of	scholarly article
main subject	wds:Q37390136-70AF0A8A-0DD2-4C09-962B-6F40642D7719
main subject	wd:Q423762
PubMed ID	wds:Q37390136-7E156B13-EB4B-4D7A-BC43-02E2AB60CA93
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/24371703
PubMed ID	24371703
published in	wds:Q37390136-1FA33C93-7183-4B46-B741-C2EA6E50C12A
published in	Gynecologic oncology case reports
volume	wds:Q37390136-8D0F6F8D-2BCA-4078-9073-6D148302DB6F
volume	5
DOI	wds:Q37390136-1A5D0391-778E-4A8D-9C2E-781200F94CA2
DOI	http://dx.doi.org/10.1016/J.GYNOR.2013.05.003
DOI	10.1016/J.GYNOR.2013.05.003
ResearchGate publication ID	wds:Q37390136-431EDF60-32C5-4873-8866-D2E2F65778CB
ResearchGate publication ID	259474354
PMCID	wds:Q37390136-E41CEE87-60B7-480A-B038-6528915D14CC
PMCID	3862232
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q37390136
is cites work of	Current Advances of Tubulin Inhibitors in Nanoparticle Drug Delivery and Vascular Disruption/Angiogenesis Initial testing (stage 1) of the tubulin binding agent nanoparticle albumin-bound (nab) paclitaxel (Abraxane(®)) by the Pediatric Preclinical Testing Program (PPTP). Strategy for selecting nanotechnology carriers to overcome immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics Re-visiting Hypersensitivity Reactions to Taxanes: A Comprehensive Review Dermatological adverse events with taxane chemotherapy Neoadjuvant triweekly nanoparticle albumin-bound paclitaxel followed by epirubicin and cyclophosphamide for Stage II/III HER2-negative breast cancer: evaluation of efficacy and safety. Nab-paclitaxel after docetaxel hypersensitivity reaction: case report and literature review. Universal tolerance of nab-paclitaxel for gynecologic malignancies in patients with prior taxane hypersensitivity reactions.
is cites work of	wds:Q28077780-9AF93B87-34B9-43E0-9941-C62794128B58 wds:Q38494470-6A723E76-164E-470F-B755-E2845835F1DC wds:Q38205153-4605BC2A-1C3F-4DDC-86F8-6017995BD3C0 wds:Q38934447-08868C46-135A-4A38-A3FE-C32828F81A98 wds:Q64992651-1076D7C0-998F-4DBD-A542-F295D01EFB08 wds:Q53008476-6A30E666-D43B-4F06-A169-5C7020DACD08 wds:Q36040758-7EF947B6-3D83-4EB7-B06D-BF9CE55ACB1D wds:Q33442096-B40D6634-383C-47EE-81BE-0FE2406FFF92

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software